(Q37773234)

22 August 2017

1 reference

title

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer (English)

1 reference

22 August 2017

0 references

0 references

6

1 reference

22 August 2017

3

Anna Merlo

1 reference

22 August 2017

1

Debora Martorelli

1 reference

22 August 2017

2

Elena Muraro

1 reference

22 August 2017

4

Riccardo Turrini

1 reference

22 August 2017

Antonio Rosato

5

1 reference

22 August 2017

publication date

1 August 2010

1 reference

International Reviews of Immunology

22 August 2017

published in

1 reference

22 August 2017

volume

29

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

371-402

1 reference

The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Multiple roles for CD4+ T cells in anti-tumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Th17 cells: a new fate for differentiating helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

T helper cell effector fates--who, how and where?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

New insights into the differentiation and function of T follicular helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Understanding the function of CD1-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

HIV-1-specific memory CD4+ T cells are phenotypically less mature than cytomegalovirus-specific memory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Cytotoxic human CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Mechanism and biological significance of CD4-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Involvement of CD80 in the generation of CD4+ cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4+CD25+ T Cells Lyse Antigen-Presenting B Cells by Fas-Fas Ligand Interaction in an Epitope-Specific Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Virus-stimulated plasmacytoid dendritic cells induce CD4+ cytotoxic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Virus-specific CD4+ T cells: ready for direct attack

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Nomenclature for Factors of the HLA System, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Phenotypic and functional separation of memory and effector human CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Immunological events in regressing genital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Properties of CD4(+) T cells in human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

HTLV-I associated myelopathy, a new clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Immunity against cancer: lessons learned from melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4 T cells and their role in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Adoptive immunotherapy of cancer using CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Location, location, location: the role of cyclin D1 nuclear localization in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The history of tumor virology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Virally targeted therapies for EBV-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Epstein-Barr virus and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Adoptive T cell therapy for cancer in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

How do cytotoxic lymphocytes kill their targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.489658

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI40202

Identifiers

DOI

10.3109/08830185.2010.489658

1 reference

22 August 2017

1 reference